1. Home
  2. VSAT vs AMPH Comparison

VSAT vs AMPH Comparison

Compare VSAT & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ViaSat Inc.

VSAT

ViaSat Inc.

HOLD

Current Price

$34.68

Market Cap

4.6B

Sector

Technology

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.84

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSAT
AMPH
Founded
1986
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
1.2B
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
VSAT
AMPH
Price
$34.68
$26.84
Analyst Decision
Buy
Buy
Analyst Count
7
6
Target Price
$33.00
$31.00
AVG Volume (30 Days)
1.5M
380.2K
Earning Date
02-05-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.27
Revenue
$4,582,796,000.00
$723,305,000.00
Revenue This Year
$5.08
$1.35
Revenue Next Year
$3.47
$5.10
P/E Ratio
N/A
$11.95
Revenue Growth
1.23
N/A
52 Week Low
$7.36
$20.39
52 Week High
$43.59
$39.01

Technical Indicators

Market Signals
Indicator
VSAT
AMPH
Relative Strength Index (RSI) 49.07 53.45
Support Level $33.72 $26.26
Resistance Level $37.46 $27.44
Average True Range (ATR) 1.98 0.79
MACD -0.01 0.06
Stochastic Oscillator 39.70 74.12

Price Performance

Historical Comparison
VSAT
AMPH

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: